Andera Partners — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Arvelle Therapeuticsangelinipharma.chinFeb 2019 · $180M
Angelini Pharma Switzerland is the Swiss arm of a pharmaceutical company focused on brain health and epilepsy, offering prescription treatments for patients and healthcare professionals.
BiotechConsumerHealthtechZug, CH
Co-investorsF-Prime CapitalH.I.G. CapitalH.I.G. HealthBridge PartnersBRV Capital ManagementH.I.G. BioHealth PartnersLife Sciences Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.